Invariant human TCR Vα24-Jα18+/Vβ11+ NKT cells (iNKT) are restricted by CD1d–α-glycosylceramides. We analyzed crystal structures and binding characteristics for an iNKT TCR plus two CD1d–α-GalCer–specific Vβ11+ TCRs that use different TCR Vα chains. The results were similar to those previously reported for MHC–peptide-specific TCRs, illustrating the versatility of the TCR platform. Docking TCR and CD1d–α-GalCer structures provided plausible insights into their interaction. The model supports a diagonal orientation of TCR on CD1d and suggests that complementarity determining region (CDR)3α, CDR3β, and CDR1β interact with ligands presented by CD1d, whereas CDR2β binds to the CD1d α1 helix. This docking provides an explanation for the dominant usage of Vβ11 and Vβ8.2 chains by human and mouse iNKT cells, respectively, for recognition of CD1d–α-GalCer.
Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors
Abbreviations used: α-GalCer, α-galactosylceramide; CDR, complementarity determining region; CNS, Crystallography and NMR system; DN, double negative; ds, disulfide-linked; iNKT, invariant NKT; J, junctional; PC, phosphatidylcholine; rmsd, root mean square deviation; V, variable.
V. Cerundolo and E.Y. Jones share senior authorship.
S.D. Gadola, M. Koch, and J. Marles-Wright contributed equally to this work.
Stephan D. Gadola, Michael Koch, Jon Marles-Wright, Nikolai M. Lissin, Dawn Shepherd, Gediminas Matulis, Karl Harlos, Peter M. Villiger, David I. Stuart, Bent K. Jakobsen, Vincenzo Cerundolo, E. Yvonne Jones; Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors . J Exp Med 20 March 2006; 203 (3): 699–710. doi: https://doi.org/10.1084/jem.20052369
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement